Oral Presentation Lorne Infection and Immunity 2019

Membrane phospholipid targeting by defensins induces fungal and tumour cell lysis (#21)

Fung T Lay 1 , Michael Järvå 1 , Thanh Kha Phan 1 , Amy A Baxter 1 , Sofia Caria 1 , Ivan K Poon 1 , Marc Kvansakul 1 , Mark D Hulett 1
  1. Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC, Australia

Cationic antimicrobial peptides (CAPs) such as defensins are ubiquitously found innate immune molecules that often exhibit broad activity against microbial pathogens and mammalian tumour cells. Many CAPs act at the plasma membrane of cells leading to membrane destabilization and permeabilization. Here we describe a novel cell lysis mechanism for fungal and tumour cells by plant and human defensins that act via direct binding to the plasma membrane phospholipids phosphatidylinositol 4,5-bisphosphate (PIP2) or phosphatidic acid (PA). We have determined the crystal structures of the plant defensins NaD1 and NsD7 in complex with PIP and PA, respectively, revealing distinct oligomeric arrangements [1-3]. Both NaD1 and NsD7 form dimers that cooperatively bind the anionic head groups of PIP2 or PA via unique “cationic grip” configurations and assemble into oligomeric fibrils. Site-directed mutagenesis of NaD1 and NsD7 confirms that phospholipid binding and oligomerization are important for fungal and tumour cell permeabilization. We have shown that human beta-defensins 2 and 3 also use similar mechanisms for cell lysis [4,5]. These observations identify a conserved innate recognition system by defensins for direct binding of phospholipid that permeabilize cells via a novel membrane disrupting mechanism.

 

  1. I.K. Poon, A.A Baxter, F.T. Lay, G.D. Mills, C.G Adda, J.A. Payne, T.K. Phan, G.F Ryan, J.A. White, P.K. Veneer, N.L. van der Weerden, M.A. Anderson, M. Kvansakul M and M.D. Hulett, eLife 3, e01808 (2014).
  2. M. Kvansakul, F.T. Lay, C.G. Adda, P.K. Veneer, A.A. Baxter, T.K. Phan, I.K. Poon and M.D Hulett.Proc. Natl. Acad. Sci. USA 113,11202 (2016).
  3. M. Järvå, F.T. Lay, T.K. Phan, C. Humble, I.K Poon, M.D. Hulett and M. Kvansakul. Nat. Commun. 9, 1962 (2018).
  4. T.K. Phan, F.T. Lay, I.K. Poon, M.G. Hinds, M. Kvansakul and M.D. Hulett. Oncotarget 7, 2054 (2016).
  5. M. Järvå, T.K. Phan, F.T. Lay, M. Kvansakul and M.D. Hulett. Science Advances 4, eaa0979 (2018)